Banque Pictet & Cie SA Reduces Stock Position in CME Group Inc. (NASDAQ:CME)

Banque Pictet & Cie SA trimmed its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 3.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 65,043 shares of the financial services provider's stock after selling 2,082 shares during the quarter. Banque Pictet & Cie SA's holdings in CME Group were worth $17,255,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Wayfinding Financial LLC bought a new stake in CME Group in the 1st quarter valued at $25,000. Cornerstone Planning Group LLC raised its stake in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Golden State Wealth Management LLC raised its stake in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Alpine Bank Wealth Management acquired a new position in CME Group in the 1st quarter valued at $32,000. Finally, New Age Alpha Advisors LLC grew its holdings in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CME. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays raised their price objective on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Keefe, Bruyette & Woods boosted their price objective on CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. UBS Group increased their target price on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Finally, JPMorgan Chase & Co. decreased their price target on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $259.87.

CME Group Stock Up 0.0%

CME Group stock traded up $0.01 during mid-day trading on Wednesday, reaching $275.64. The stock had a trading volume of 2,841,477 shares, compared to its average volume of 2,196,408. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $193.17 and a fifty-two week high of $290.79. The stock's 50-day simple moving average is $276.76 and its 200-day simple moving average is $258.61. The firm has a market capitalization of $99.33 billion, a PE ratio of 27.73, a price-to-earnings-growth ratio of 3.83 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter last year, the firm posted $2.50 earnings per share. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. On average, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.81%. CME Group's dividend payout ratio (DPR) is currently 50.30%.

Insider Buying and Selling at CME Group

In related news, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director owned 3,668 shares in the company, valued at approximately $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard acquired 256 shares of CME Group stock in a transaction on Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 13,400 shares of company stock valued at $3,680,610 in the last three months. Insiders own 0.30% of the company's stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.